Drug Search Results
More Filters [+]

GS-0174

Alternative Names: GS-0174, GS0174, GS 0174, FSI-174, FSI174
Latest Update: None
Latest Update Note: None

Product Description

GS-0174 is a anti-c KIT drug candidate for Gilead Sciences used for transplant conditioning regimens. (Sourced from: https://www.gilead.com/science-and-medicine/pipeline)

Mechanisms of Action: C-KIT Antagonist

Novel Mechanism: No

Modality: Antibody

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GS-0174

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title